Emergent’s Narcan nasal spray receives OTC nod for opioid overdose treatment
Emergent BioSolutions’ Narcan nasal spray has secured over-the-counter (OTC) designation from the US Food and Drug Administration (FDA), becoming the first and only prescription strength naloxone nasal spray to receive the status in the country. Narcan Naloxone HCl nasal spray 4 mg is indicated for emergency treatment of opioid overdose, including illegal fentanyl, in the […]